Humco, a diversified, global pharmaceutical company, announced today that their Board of Directors has entered into a definitive merger agreement under which Humco will combine with Fagron, the global leader in pharmaceutical compounding and personalized medicine, for a value of up to US $70 million.
April 3, 2018
· 3 min read
